UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of report (Date of earliest event reported):
COMMISSION
FILE NO.
(Exact name of registrant as specified in Charter)
| 8713 | ||||
(State or other jurisdiction of incorporation or organization) |
IRS Employer Identification Number |
Primary Standard Industrial Classification Code Number |
EvoAir Holdings Inc.
(Address of Principal Executive Offices)
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| OTC Markets – Pink Sheet |
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On March 29, 2023, Mr. Tan Soon Hock has submitted a resignation letter notifying the Company of his intention to retire as non-executive director of the Company due to personal reasons, effective April 1, 2023. There were no disagreements between Mr. Tan Soon Hock and the Company on any matter relating to the Company’s operations, policies or practices, which resulted in his resignation.
On April 1, 2023, the board of directors (the “Board”) appointed Mr. Chan Hong Fook to the Board, effective immediately, to fill the vacancy. Mr. Chan Hong Fook will serve as an independent non-executive director of the Company.
Set forth below is information regarding the Company’s newly appointed director:
Mr. Chan Hong Fook, aged 55, is an Independent Non-Executive Director of the Company. Mr. Chan has had over 25 years of experience in sales and marketing. Mr. Chan is the founder and director of Epic Ingredients Sdn Bhd since 1998, where he is responsible for the company’s affairs and management on a day to day basis. Mr. Chan is also the Non-Executive Chairman of Axiana Pharmacy Sdn Bhd and All Day Pharmacy Sdn Bhd since June 2017. Mr. Chan graduated with a Diploma of Management from Systematic College.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| EvoAir Holdings Inc. | ||
| By: | /s/ Low Wai Koon | |
| Name: | Low Wai Koon | |
| Title: | Chairman, President and Chief Executive Officer (Principal Executive Officer) | |
Date: April 4, 2023